INCIDENCE OF CYTOGENETIC ABNORMALITIES IN NEWLY DIAGNOSED BINET STAGE A B-CLL AND RELATIONSHIP WITH PROGNOSTIC BIOMARKERS: UPDATED RESULTS ON 319 PATIENTS INCLUDED IN THE PROSPECTIVE O-CLL1 GISL STUDY